These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 18986780

  • 1. Evaluation of orally administered valacyclovir in experimentally EHV1-infected ponies.
    Garré B, Gryspeerdt A, Croubels S, De Backer P, Nauwynck H.
    Vet Microbiol; 2009 Mar 30; 135(3-4):214-21. PubMed ID: 18986780
    [Abstract] [Full Text] [Related]

  • 2. Multiple oral dosing of valacyclovir in horses and ponies.
    Garré B, Baert K, Nauwynck H, Deprez P, De Backer P, Croubels S.
    J Vet Pharmacol Ther; 2009 Jun 30; 32(3):207-12. PubMed ID: 19646083
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of the early administration of valacyclovir hydrochloride for the treatment of neuropathogenic equine herpesvirus type-1 infection in horses.
    Maxwell LK, Bentz BG, Gilliam LL, Ritchey JW, Pusterla N, Eberle R, Holbrook TC, McFarlane D, Rezabek GB, Meinkoth J, Whitfield C, Goad CL, Allen GP.
    Am J Vet Res; 2017 Oct 30; 78(10):1126-1139. PubMed ID: 28945127
    [Abstract] [Full Text] [Related]

  • 4. Effects of valacyclovir in cats infected with feline herpesvirus 1.
    Nasisse MP, Dorman DC, Jamison KC, Weigler BJ, Hawkins EC, Stevens JB.
    Am J Vet Res; 1997 Oct 30; 58(10):1141-4. PubMed ID: 9328668
    [Abstract] [Full Text] [Related]

  • 5. Differences in replication kinetics and cell tropism between neurovirulent and non-neurovirulent EHV1 strains during the acute phase of infection in horses.
    Gryspeerdt AC, Vandekerckhove AP, Garré B, Barbé F, Van de Walle GR, Nauwynck HJ.
    Vet Microbiol; 2010 May 19; 142(3-4):242-53. PubMed ID: 19926232
    [Abstract] [Full Text] [Related]

  • 6. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA.
    Sex Transm Dis; 2008 Mar 19; 35(3):286-90. PubMed ID: 18157071
    [Abstract] [Full Text] [Related]

  • 7. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R, Wald A, Krantz E, Selke S, Warren T, Vargas-Cortes M, Miller G, Corey L.
    J Infect Dis; 2004 Oct 15; 190(8):1374-81. PubMed ID: 15378428
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.
    Kimberlin DW, Jacobs RF, Weller S, van der Walt JS, Heitman CK, Man CY, Bradley JS.
    Clin Infect Dis; 2010 Jan 15; 50(2):221-8. PubMed ID: 20014952
    [Abstract] [Full Text] [Related]

  • 9. Valacyclovir for the management of herpes viral infections.
    Chakrabarty A, Anderson NJ, Beutner R, Tyring SK.
    Skin Therapy Lett; 2005 Feb 15; 10(1):1-4. PubMed ID: 15776202
    [Abstract] [Full Text] [Related]

  • 10. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB, Drolette L, Koelle DM, Almekinder J, Warren T, Tyring S, Wald A.
    Sex Transm Dis; 2008 Apr 15; 35(4):383-6. PubMed ID: 18362859
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Valacyclovir. New indication: for genital herpes, simpler administration.
    Can Fam Physician; 1999 Jul 15; 45():1698-700, 1703-5. PubMed ID: 10424269
    [Abstract] [Full Text] [Related]

  • 13. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
    Coombs DK, Patton T, Kohler AK, Soboll G, Breathnach C, Townsend HG, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):109-16. PubMed ID: 16473413
    [Abstract] [Full Text] [Related]

  • 14. The effect of valacyclovir treatment on natural killer cells of infertile women.
    Thomas D, Michou V, Tegos V, Patargias T, Moustakarias T, Kanakas N, Mantzavinos T, Apostolidis C, Salamalekis E, Kalofoutis A, Tsilivakos V.
    Am J Reprod Immunol; 2004 Mar 15; 51(3):248-55. PubMed ID: 15209395
    [Abstract] [Full Text] [Related]

  • 15. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C.
    J Infect Dis; 2007 Nov 15; 196(10):1500-8. PubMed ID: 18008230
    [Abstract] [Full Text] [Related]

  • 16. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
    van der Meulen K, Caij B, Pensaert M, Nauwynck H.
    Vet Microbiol; 2006 Mar 31; 113(3-4):265-73. PubMed ID: 16387454
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of penciclovir after oral administration of its prodrug famciclovir to horses.
    Tsujimura K, Yamada M, Nagata S, Yamanaka T, Nemoto M, Kondo T, Kurosawa M, Matsumura T.
    J Vet Med Sci; 2010 Mar 31; 72(3):357-61. PubMed ID: 19959884
    [Abstract] [Full Text] [Related]

  • 18. Valacyclovir for the treatment of genital herpes.
    Brantley JS, Hicks L, Sra K, Tyring SK.
    Expert Rev Anti Infect Ther; 2006 Jun 31; 4(3):367-76. PubMed ID: 16771614
    [Abstract] [Full Text] [Related]

  • 19. Vitreous penetration of orally administered valacyclovir.
    Huynh TH, Johnson MW, Comer GM, Fish DN.
    Am J Ophthalmol; 2008 Apr 31; 145(4):682-6. PubMed ID: 18226802
    [Abstract] [Full Text] [Related]

  • 20. Response of pregnant mares to equine herpesvirus 1 (EHV1).
    Gleeson LJ, Coggins L.
    Cornell Vet; 1980 Oct 31; 70(4):391-400. PubMed ID: 6257449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.